Skip to content

Clinical trials

Phase 2 Sjogren's Syndrome trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sjogren's Syndrome Phase: Phase 2 Country / region: United Kingdom Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20162
20172
20193
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Amgen2
Gilead Sciences1
GlaxoSmithKline1
Hoffmann-La Roche1
Institut de Recherches Internationales Servier1
Resolve Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sjogren's Syndrome11
Autoimmune Diseases4
Arthritis2
Dry Eye Syndromes2
Joint Diseases2
Salivary Gland Diseases2
Xerostomia2
Connective Tissue Diseases1
Eye Diseases1
Fatigue1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.